Skip to main content
CTVA
NYSE Industrial Applications And Services

Corteva Reports Strong Q1 Earnings, Details $1.5B Pension Contribution and Major Litigation Settlements

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Neutral
Importance info
8
Price
$81.77
Mkt Cap
$54.897B
52W Low
$60.535
52W High
$85.63
52W Position info
35% above low
Off High info
4.5% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

CTVA sits 35% above its 52-week low of $60.535.

Summary

Corteva reported strong Q1 2026 financial results with increased sales and earnings, while detailing significant cash outflows for a $546M Bayer settlement payment and a planned $1.5B pension contribution, alongside ongoing restructuring efforts.


Key Events · Earnings and Guidance · CTVA

  • Strong Q1 Financial Performance

    Net sales increased 11% to $4.905 billion, diluted EPS rose 12.6% to $1.07, and operating EBITDA grew 21% to $1.438 billion compared to Q1 2025, driven by volume growth and favorable currency impacts.

  • Significant Bayer Litigation Settlement Payment

    The company made a $546 million payment in Q1 2026 as part of a $610 million settlement to resolve disputes with Bayer, with the remaining balance due by September 15, 2026.

  • Planned $1.5 Billion Pension Contribution

    The Board of Directors approved a $1.5 billion contribution to the principal U.S. pension plan, expected to be made by July 31, 2026, aimed at strengthening the plan ahead of the proposed business separation.

  • Ongoing Restructuring Actions

    Corteva recorded $78 million in pre-tax restructuring charges in Q1 2026 related to the 2026 Restructuring Actions, which are designed to align the organizational structure with the planned business separation and are expected to yield $115M-$125M in annual savings by 2027.


Analysis · CTVA · Industrial Applications And Services

Corteva's first-quarter results demonstrate robust operational performance with double-digit growth in sales and earnings, exceeding analyst expectations. However, the detailed 10-Q reveals significant cash outflows, including a $546 million payment for the Bayer litigation settlement and a planned $1.5 billion contribution to the U.S. pension plan by July 2026. These substantial cash uses, alongside ongoing restructuring efforts and other litigation accruals, provide critical context to the company's financial health and capital allocation strategy, especially as it prepares for a proposed business separation. Investors should monitor the impact of these outflows on future liquidity and the execution of the separation plan.

At the time of this filing, CTVA was trading at $81.77 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $54.9B. The 52-week trading range was $60.54 to $85.63. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTVA - Latest Insights

CTVA
Jul 31, 2026, 5:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $78.80
Real-time Price: $78.80 info
Change: $0 (0%) info
Market Cap: $52.643B info
CTVA
Jul 31, 2026, 12:16 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $79.88
Real-time Price: $78.80 info
Change: -$1.08 (-1%) info
Market Cap: $52.643B info
CTVA
Jul 30, 2026, 4:44 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $84.14
Real-time Price: $78.80 info
Change: -$5.34 (-6%) info
Market Cap: $52.643B info
CTVA
Jul 30, 2026, 4:30 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $82.01
Real-time Price: $78.80 info
Change: -$3.21 (-4%) info
Market Cap: $52.643B info
CTVA
Jul 06, 2026, 7:19 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $85.80
Real-time Price: $78.80 info
Change: -$7.00 (-8%) info
Market Cap: $52.643B info